At the conclusion of the experiment, TKO + TCR SP8 T cells showed significantly improved tumour control compared with mice that received either no T cells or WT + TCR SP8 T cells (Fig. 8b–d), and they showed improved survival compared with mice that received no T cells (Supplementary Fig. 10e). The gene discussed is SP8; the disease is neoplasm.